20 ML sodium glycerophosphate 216 MG/ML Injection [Glycophos]
RxNorm concept 1423812, branded drug (sbd). Prescribable name: Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 ML Injection.
- RxCUI
- 1423812
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1423812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
20 ML Glycophos 216 MG/ML Injection; Glycophos 4.32 GM (sodium 40 mmol, phosphate 20 mmol) per 20 ML Injection
Related concepts
- sodium glycerophosphate 216 MG/ML (SCDC, consists of)
- sodium glycerophosphate 216 MG/ML [Glycophos] (SBDC, consists of)
- Injection (DF, has dose form)
- Glycophos (BN, has ingredient)
- 20 ML sodium glycerophosphate 216 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
- 63323024120
- 65219034601
- 65219034620
- 65219034801
- 65219034810
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1423812 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1423812 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1423812. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.